2219.HK Tiesioginiai signalai | Didinkite pelną su Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 bal. 2024 @ 11:08):

Stats
Šios dienos apimtis	450 500
Vidutinė apimtis	1.25M
Rinkos kapitalizacija	2.60B
EPS	HKD0 ( 2024-03-28 )
Kita pelno data	( HKD0 ) 2024-06-06
Last Dividend	HKD0.174 ( 2023-06-12 )
Next Dividend	HKD0 ( N/A )
P/E	10.39
ATR14	HKD0.00700 (0.19%)

Tūris Koreliacija

Ilgas: 0.13 (neutral)

Trumpas: -0.92 (very strong negative)

Signal:(41.352) Neutral

Chaoju Eye Care Holdings Koreliacija

10 Labiausiai teigiamai susiję koreliacijos

10 Labiausiai neigiamai susiję koreliacijos

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

Chaoju Eye Care Holdings Koreliacija - Valiuta/Žaliavos

0.54
( weak )

0.64
( weak )

0.00
( neutral )

-0.54
( weak negative )

Chaoju Eye Care Holdings Finansinės ataskaitos

Annual	2023
Pajamos:	HKD1.37B
Bruto pelnas:	HKD621.13M (45.35 %)
EPS:	HKD0.330

FY	2023
Pajamos:	HKD1.37B
Bruto pelnas:	HKD621.13M (45.35 %)
EPS:	HKD0.330

FY	2022
Pajamos:	HKD990.04M
Bruto pelnas:	HKD434.70M (43.91 %)
EPS:	HKD0.270

FY	2021
Pajamos:	HKD997.79M
Bruto pelnas:	HKD448.67M (44.97 %)
EPS:	HKD0.235

Financial Reports:

No articles found.

Chaoju Eye Care Holdings Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0.174 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)

Chaoju Eye Care Holdings Dividend Information - Ex Dividend Knight

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 4.93 - Stable (1.41%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	HKD0.104	2022-06-10
Last Dividend	HKD0.174	2023-06-12
Next Dividend	HKD0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	2	--
Total Paid Out	HKD0.278	--
Avg. Dividend % Per Year	0.00%	--
Score	3.03	--
Div. Sustainability Score	10.00
Div.Growth Potential Score	4.93
Div. Directional Score	8.35	--

Next Divdend (Est)
(2025-03-31)

HKD0.232 Estimate 3.00 %

Dividend Stability

0.24 Very Poor

Dividend Score

3.03

Pay Frequency

Annually

Yearly Payout

Year	Amount	Yield

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for HKSE

Symbol	Title	Last dividend	Frequency	Yearly Dividend
2359.HK	Ex Dividend Knight	2023-06-05	Annually	0.00%
1345.HK	Ex Dividend Junior	2023-10-04	Semi-Annually	0.00%
0390.HK	Ex Dividend Junior	2023-07-19	Annually	0.00%
6626.HK	Ex Dividend Knight	2023-09-04	Annually	0.00%
1897.HK	Ex Dividend Knight	2023-07-05	Semi-Annually	0.00%
0921.HK	Ex Dividend Junior	2023-07-10	Sporadic	0.00%
0052.HK	Ex Dividend Knight	2023-09-12	Semi-Annually	0.00%
2869.HK	Ex Dividend Junior	2023-06-20	Annually	0.00%
1469.HK	Ex Dividend Knight	2023-08-29	Semi-Annually	0.00%
0546.HK	Ex Dividend Knight	2023-09-18	Semi-Annually	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.167	1.500	6.66	9.99	[0 - 0.5]
returnOnAssetsTTM	0.0783	1.200	7.39	8.87	[0 - 0.3]
returnOnEquityTTM	0.0982	1.500	-0.0200	-0.0300	[0.1 - 1]
payoutRatioTTM	0.479	-1.000	5.21	-5.21	[0 - 1]
currentRatioTTM	5.05	0.800	10.00	8.00	[1 - 3]
quickRatioTTM	3.34	0.800	10.00	8.00	[0.8 - 2.5]
cashRatioTTM	1.352	1.500	3.60	5.40	[0.2 - 2]
debtRatioTTM	0.0544	-1.500	9.09	-10.00	[0 - 0.6]
interestCoverageTTM	44.90	1.000	10.00	10.00	[3 - 30]
operatingCashFlowPerShareTTM	0.540	2.00	9.82	10.00	[0 - 30]
freeCashFlowPerShareTTM	0.540	2.00	9.73	10.00	[0 - 20]
debtEquityRatioTTM	0.0674	-1.500	9.73	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.454	1.000	5.77	5.77	[0.2 - 0.8]
operatingProfitMarginTTM	0.211	1.000	7.77	7.77	[0.1 - 0.6]
cashFlowToDebtRatioTTM	2.34	1.000	10.00	10.00	[0.2 - 2]
assetTurnoverTTM	0.469	0.800	-0.210	-0.168	[0.5 - 2]
Total Score				11.78

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	10.44	1.000	9.05	0	[1 - 100]
returnOnEquityTTM	0.0982	2.50	-0.0128	-0.0300	[0.1 - 1.5]
freeCashFlowPerShareTTM	0.540	2.00	9.82	10.00	[0 - 30]
dividendYielPercentageTTM	5.02	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	0.540	2.00	9.82	10.00	[0 - 30]
payoutRatioTTM	0.479	1.500	5.21	-5.21	[0 - 1]
pegRatioTTM	0.177	1.500	-2.15	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.272	1.000	5.70	0	[0.1 - 0.5]
Total Score				4.93

Chaoju Eye Care Holdings

Chaoju Eye Care Holdings Limited owns and operates a network of ophthalmic hospitals and optical centers in China. Its consumer ophthalmic services include treatments and prevention for various ophthalmic disorders, such as refractive and presbyopia correction, and myopia control, as well as optical products and services. The company also provides basic ophthalmic services, including cataract, glaucoma, ocular fundus diseases, ocular muscle diseases, refraction errors, pediatric ophthalmology, ocular surface diseases, lacrimal diseases, orbital diseases, oculoplastic, and ocular trauma. As of December 31, 2021, it operated a network of 17 ophthalmic hospitals, 24 optical centers, and 2 clinics in Zhejiang, Jiangsu, Shanxi, and Hebei provinces, as well as in Inner Mongolia. The company was founded in 1988 and is headquartered in Beijing, China.